Wolfe Research initiated coverage of AbbVie (ABBV) with an Outperform rating and $205 price target
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABBV:
- JPMorgan trims AbbVie target, removes from Analyst Focus List
- Elliott confirms big Honeywell stake, Home Deport reports Q3 beat: Morning Buzz
- Bristol Myers price target raised to $61 from $57 at BMO Capital
- Nvidia initiated, Airbnb downgraded: Wall Street’s top analyst calls
- AbbVie price target lowered to $208 from $228 at BMO Capital
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue